Cite

HARVARD Citation

    Miyares, M. et al. (n.d.). Idarucizumab, a Humanized, Monoclonal Antibody Fragment for Immediate Reversal of Dabigatran. Journal of pharmacy practice. pp. 548-554. [Online]. 
  
Back to record